I appreciate your personalized customer service and prompt follow up. All I can say is this, if you are this straight forward and direct when something goes wrong, then you treat your customers with respect. And if you do that on a regular basis, you deserve to have great things happen to you in the future.
I will be in touch.
Thanks.
NuPathe to Present at Upcoming Investor Conferences - MarketWatch (press release)
NuPathe to Present at Upcoming Investor ConferencesMarketWatch (press release)NuPathe's lead product candidate, NP101, is an active, single-use, transdermal sumatriptan patch being developed for the treatment of migraine.
OptiNose to begin Phase III trials with intranasal technology - Pharmaceutical Business Review
OptiNose to begin Phase III trials with intranasal technologyPharmaceutical Business ReviewOptiNose, a drug delivery company, has filed an investigational new drug (IND) with the FDA to use sumatriptan delivered with its novel drug delivery technology, in December 2011.
OptiNose testing nose-to-brain delivery tech with migraine drug - FierceDrugDelivery
OptiNose testing nose-to-brain delivery tech with migraine drugFierceDrugDeliveryOptiNose is launching a Phase III trial to test the migraine drug sumatriptan with its intranasal nose-to-brain drug delivery technology.
NuPathe Announces Allowance of Additional U.S. Patent Application for Its ... - MarketWatch (press release)
NuPathe Announces Allowance of Additional U.
Vibex MTX: The Cherry On Top Of The Antares Investment Story - Seeking Alpha
Vibex MTX: The Cherry On Top Of The Antares Investment StorySeeking AlphaFor example, I am modeling generic launches by Teva of the epinephrine and sumatriptan injectors, but if Teva settles with the innovators or agrees to launch an authorized generic, these estimates could be very different.